Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹273 Cr₹205 Cr₹84 Cr₹57 Cr₹24 Cr

What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?

The latest Total Non-Current Liabilities ratio of MARKSANS PHARMA is ₹273 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹273 Cr
Mar2024₹205 Cr
Mar2023₹84 Cr
Mar2022₹57 Cr
Mar2021₹24 Cr

How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹273 Cr
33.00
Mar2024 ₹205 Cr
143.34
Mar2023 ₹84 Cr
47.80
Mar2022 ₹57 Cr
140.72
Mar2021 ₹24 Cr -

Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹10,917.6 Cr -12.6% -5.9% -0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,179.0 Cr -0.4% 4.3% 13.6% Stock Analytics
DIVIS LABORATORIES ₹193,860.0 Cr 0.9% 8.9% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,530.0 Cr 0.7% 13% 46.5% Stock Analytics
CIPLA ₹112,593.0 Cr -1% -0% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,364.9 Cr -3.3% -8.4% -4.3% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-12.6%

-5.9%

-0.3%

SENSEX

-0.6%

-0.1%

-6.7%


You may also like the below Video Courses